Results 31 to 40 of about 57,073 (212)
Zolmitriptan: a novel portal hypotensive agent which synergizes with propranolol in lowering portal pressure. [PDF]
PLoS ONE, 2013 OBJECTIVE: Only a limited proportion of patients needing pharmacological control of portal hypertension are hemodynamic responders to propranolol.
Mercedes Reboredo +13 more
doaj +1 more source
International Journal of Pediatrics, 2021 Objective. Low-dose nonselective β blockade is an effective treatment for problematic infantile hemangioma (PIH). Screening electrocardiograms (ECG) are performed prior to the initiation of propranolol to minimize the risk of exacerbating undiagnosed ...
James D. Phillips +9 more
doaj +1 more source
The anti-cancer effect of Propranolol in K562 cell line: an in vitro study
Armaghane Danesh Bimonthly Journal, 2016 Introduction: Β-AR receptors are one of the proteins involved in cancer and stress. The therapeutic activity of β-blockers such as propranolol is attributed to the blockade of β1-adrenergic receptors (ARs).
S Bastani, M Mohamadzade, Y Pazhang
doaj
Gastroenterology Research and Practice, 2020 Alcoholic cirrhosis (AC) leads to enormous disease burden and occupies a substantial proportion in the etiology of hepatocellular carcinoma (HCC), but scarce attention has been paid to this topic.
Tzu-Hao Li +13 more
doaj +1 more source
Veterinary Medicine and Science, 2023 Background No study has been performed regarding the effects of oral administration of propranolol on pulse‐wave spectral Doppler indices of major abdominal vessels in healthy adult cats. Objective The objective of this study was to assess the pulse‐wave
Shima Amini Masouleh +3 more
doaj +1 more source
Treatment With Propranolol for Infantile Hemangioma in 13 Taiwanese Newborns and Young Infants
Pediatrics and Neonatology, 2012 Hemangioma in infants has a benign self-limited course, but the 10% of cases with complications need further treatment. Successful treatment with propranolol in western countries has been reported over the past few years.
Teng-Chin Hsu +6 more
doaj +1 more source
New onset bronchial asthma following oral propranolol for infantile hemangioma
Respiratory Medicine Case ReportsPropranolol, a nonselective adrenergic beta-receptor blocker, is the first-line drug used for the treatment of infantile hemangiomas (IH). However, its use is contraindicated in patients with bronchial asthma.
Yuki Yamaguchi +4 more
doaj +1 more source
International Journal of Pediatrics, 2021 Purpose. Propranolol has been successful in treating problematic infantile hemangiomas (IH) but concerns regarding its effect on normal growth and development have been raised.
Rachel A. Giese +4 more
doaj +1 more source
Propranolol in the Treatment of Infantile Hemangiomas
Clinical, Cosmetic and Investigational Dermatology, 2021 Xin Tan, Shu Guo, Chenchao Wang Department of Plastic Surgery, First Hospital of China Medical University, Shenyang, Liaoning Province, People’s Republic of ChinaCorrespondence: Chenchao WangDepartment of Plastic Surgery, First Hospital of China Medical ...
Tan X, Guo S, Wang C
doaj
eLife, 2019 Propranolol is an approved non-selective β-adrenergic blocker that is first line therapy for infantile hemangioma. Despite the clinical benefit of propranolol therapy in hemangioma, the mechanistic understanding of what drives this outcome is limited ...
Jeroen Overman +17 more
doaj +1 more source